Skip to main content



Evidence Generation Lead, Nordic CoE

応募後で応募 求人ID R0020680 掲載日 06/26/2020 Location:Taastrup, Denmark

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that I agree with Takeda’s Privacy Notice, Privacy Policy and Terms of Use.

Job Description

CoE Evidence Generation Lead, Nordics

Are you looking for a patient-focused, innovation-driven company that will inspire you and support your career? If so, be empowered to take charge of your future at Takeda. We believe that the Nordic region offers unique opportunities for evidence generation. Join us to build a Centre of Excellence for  Evidence Generation in the Nordic region.

A Typical Day Will Include:

As a CoE Early Evidence Generation Lead working on the Evidence Generation Center of Excellence Team, you will be empowered to:

  • Lead non interventional (retrospective or prospective) evidence generation projects from concept to publication by partnering with external academic experts, external vendors and internal stakeholder
  • Support the study planning process across the EUCAN region for both the Oncology and GI portfolio
  • Closely collaborate with Global, Regional and Local Takeda affiliates to understand their key evidence needs from Ph I onward in Oncology, GI and Neurosciences
  • Provide expertise on how to analyze, integrate and communicate the consolidated data generated by Takeda globally and through CoEs, and how best to present these data to different archetypes:
    • Meta-analysis/ extensive statistical analysis
    • Outcome research
    • Indirect treatment comparison
    • Health economic modeling
  • Integrated evidence analysis plans (e.g., RCT and real world data combination)
  • Provide guidance and support in evidence execution and communication to EUCAN LOCs to address challenging evidence generation questions

Role Scope:

Geographical scope

  • Evidence generation, best practice and knowledge sharing as well as support in planning and executing studies across all EUCAN local operating companies
  • Through CoE-lead, indirect touchpoints with the region (EUCAN) and Global through the EUCAN Evidence and Value Demonstration Hub to ensure status updates on ongoing activities

TA scope (full portfolio – from Ph I onwards)

  • Neurosciences (e.g., schizophrenia)
  • Oncology (e.g., multiple myeloma, HL, ALK+ NSCLC)
  • GI (e.g., inflammatory bowel disease)
  • Throughout the asset lifecycle, starting from Phase I to Phase IV/LCM


The ideal candidate would have

  • MSc or PhD in a scientific area (human biology, medicine, statistics, health economics)
  • Several years (>3 years) of experience in the pharmaceutical industry/ CRO in evidence generation (health economic modeling/ outcome research/ data analysis) or in clinical development. Experience in a relevant therapeutic area is an advantage (Oncology, GI, Neurosciences)
  • Proven knowledge of a evidence generation activities (HEOR modeling, RWE, indirect treatment comparisons, PRO or interventional studies).
  • Understanding of the lifecycle of the compounds, competition, disease area
  • Ability to think ahead and out of the box, take a structured approach to planning and securing support / buy-in for own ideas
  • Ability to work and integrate collaboratively the view of a large, international and cross-functional team
  • Joy in organizing and conducting training sessions and strong social skills to interact with external stakeholders (e.g., medical experts)
  • Demonstrated sense of urgency and strong goal orientation, an ability to make decisions and a history of meeting deadlines and objectives
  • Excellent oral and written English communication skills
  • Willingness to live/locate in Asker, Copenhagen, Stockholm or Helsinki.
  • Desire to put people first and demonstrate the values of Takeda-ism


Taastrup, Denmark

Worker Type


Worker Sub-Type


Time Type

Full time